San Diego-based Illumina Inc. (Nasdaq: ILMN) has completed its acquisition of Verinata Health Inc., a provider of non-invasive tests for the early identification of fetal chromosomal abnormalities.
Verinata Health now becomes a wholly owned subsidiary of Illumina.
Illumina will have access to Verinata’s verifi prenatal test and to its intellectual property portfolio.
The verifi test will continue to be offered through Verinata’s CLIA- and CAP-accredited laboratory, and the company will continue to generate the clinical data necessary for future regulatory submissions.
9885 Towne Centre Dr.
San Diego, CA 92121